In patients with acute coronary syndromes, healed culprit plaques were associated with a higher 1-year all-cause rehospitalization rate compared to non-healed plaques (32.7% vs. 16.5%; p=0.013).
Cohort (n=376)
Does the presence of healed culprit plaques on OCT affect plaque vulnerability and 1-year clinical outcomes in patients with acute coronary syndromes?
Healed culprit plaques are present in over a quarter of ACS patients and are associated with greater plaque vulnerability, local/systemic inflammation, and higher 1-year rehospitalization rates.
Absolute Event Rate: 32.7% vs 16.5%
p-value: p=0.013
BACKGROUND Healed plaques, morphologically characterized by a layered phenotype, are frequently found in subjects with sudden cardiac death. However, in vivo data are lacking. OBJECTIVES The purpose of this study was to determine the prevalence, morphological characteristics, and clinical significance of healed culprit plaques in patients with acute coronary syndromes (ACS) using optical coherence tomography (OCT). METHODS A total of 376 ACS patients (252 ST-segment elevation myocardial infarction MI and 124 non-ST-segment elevation acute coronary syndrome) who had undergone pre-intervention OCT imaging of the culprit lesion were enrolled. Patients were stratified according to the presence of layered phenotype, defined as layers of different optical density at OCT. Clinical and laboratory data, OCT characteristics, and 1-year outcome were compared between the 2 groups. RESULTS Among 376 patients, 108 (28.7%) healed plaques were identified. Hyperlipidemia, diabetes, and history of MI were more frequent in patients with healed plaques (44.4% vs. 33.2%; p = 0.041; 35.2% vs. 23.5%; p = 0.021; and 15.7% vs. 6.3%; p = 0.009, respectively). High-sensitivity C-reactive protein was significantly higher in patients with healed plaques (median 4.98 mg/l interquartile range: 1.00 to 11.32 mg/l vs. 3.00 mg/l interquartile range: 0.30 to 10.15 mg/l; p = 0.029). Plaque rupture (64.8% vs. 53.0%; p = 0.039), thin cap fibroatheroma (56.5% vs. 42.5%; p = 0.016), and macrophage accumulation (81.1% vs. 63.4%; p = 0.001) were common in the layered group. OCT also revealed greater area stenosis in plaques with layered phenotype (79.2 ± 9.5% vs. 74.3 ± 14.3%; p = 0.001). The incidence of major adverse cardiovascular events was similar between the 2 groups, except that the all-cause rehospitalization rate was higher among healed plaques (32.7% vs. 16.5%; p = 0.013). CONCLUSIONS Healed plaques, a signature of prior plaque destabilization, were found at the culprit site in more than one-quarter of ACS patients. Such patients more frequently were diabetic, were hyperlipidemic, or had a history of MI. Healed plaques frequently showed OCT features of vulnerability with evidence of local and systemic inflammation. The combination of plaque vulnerability, local inflammation, and greater plaque burden in addition to systemic inflammation may outweigh the protective mechanism of plaque healing and predispose those plaques to develop occlusive thrombus.
Fracassi et al. (2019) conducted a cohort in Acute Coronary Syndromes (n=376). Healed culprit plaques (layered phenotype) vs. Non-healed plaques was evaluated on All-cause rehospitalization (p=0.013). In patients with acute coronary syndromes, healed culprit plaques were associated with a higher 1-year all-cause rehospitalization rate compared to non-healed plaques (32.7% vs. 16.5%; p=0.013).